Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002614:Chelating Agents / Q000627:therapeutic use*; D002712:Chlorides / Q000627:therapeutic use; D003300:Copper / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006834:Hydrazines / Q000627:therapeutic use; D051379:Mice; D009368:Neoplasm Transplantation; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012510:Sarcoma 180 / Q000188:drug therapy*; D013229:Stearic Acids / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014499:Uracil Mustard / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D002614:Chelating Agents; D002712:Chlorides; D004273:DNA, Neoplasm; D006834:Hydrazines; D012334:RNA, Neoplasm; D013229:Stearic Acids; D013882:Thiosemicarbazones; D003300:Copper; D013866:Thioguanine; D005472:Fluorouracil; D014499:Uracil Mustard